Washington, October 12 /PRNewswire/ — Artificial intelligence (AI) has the potential to transform healthcare, but realizing this promise requires careful regulation—especially for the most vulnerable patients in the United States. The Association for Diagnostics & Laboratory Medicine (ADLM) invites stakeholders to understand how AI is currently being used in healthcare, the benefits and limitations of this evolving technology, and what actions Congress must take to ensure the careful and ethical use of medical AI.
AI is rapidly transforming how healthcare institutions manage operations, analyze data, and diagnose diseases. Since clinical laboratories generate approximately 80% of the data underlying medical decisions, laboratory medicine is at the core of efforts to leverage AI for improved patient care.
During this briefing, senior experts in laboratory medicine will discuss how AI is transforming their field and the broader healthcare industry, and introduce the five most important policy changes driving the efficient and effective development of AI. The speakers will also present a case study from pediatric health to illustrate the potential of this technology and the challenges that remain.
Attendees will gain a better understanding of Congress's role in establishing appropriate AI oversight and regulation, and what conditions are needed to ensure this technology benefits all patients—especially children.
Time: Lunch Briefing, Tuesday, October 13, 12:00 PM to 1:00 PM
Location: Room 330, Cannon House Office Building
Attendees:
- Moderator: Dr. Dennis J. Dietzen, Director of Pathology and Laboratory Medicine at Phoenix Children's Hospital
- Speaker: Dr. Sarah Wheeler, Director of Clinical Pathology, University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh
- Speaker: Dr. Stephen Master, Deputy Director of Innovation, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia
To respond, send an email to Christine DeLong, Editor and Director of Media Relations at ADLM, at [email protected].
Regarding the American Association for Clinical Laboratory Science (ADLM)
ADLM is dedicated to achieving better health for all through laboratory medicine, uniting over 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from more than 110 countries worldwide. The ADLM community is at the forefront of multiple subfields of laboratory medicine, including clinical chemistry, molecular diagnostics, mass spectrometry, clinical microbiology, and data science, with members holding a wide range of laboratory-related degrees, certifications, and qualifications. Since 1948, ADLM has advanced laboratory medicine by promoting scientific collaboration, knowledge sharing, and the development of innovative solutions that improve health outcomes. For more information, visit www.myadlm.org.
Christine DeLong
ADLM
Director of Communications and Media Relations
(p) 202.835.8722
[email protected]
Bill Malone
ADLM
Senior Director of Strategic Communications
(p) 202.835.8756
[email protected]
Source: Association for Diagnostics & Laboratory Medicine (ADLM)